APEPTICO Forschung und Entwicklung is a biotechnology company developing peptide-based products targeting chronic and life-threatening diseases. APEPTICO’s peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company also offers PEPBASE, a development platform that combines structural, functional, and clinical data from relevant biopharmaceuticals and well-characterized proteins.